Hoofa, on what basis are you saying it is seriously undervalued?
If you assume $1.2m EBITDA for FY18 as guided and then add back the R&D spend of $1.0m (which you could argue, given many companies would capitalise it and also the R&D tax incentive will likely be claimed and add back to cash income), or $2.2m EBITDA adjusted for R&D, then it's trading on approx ~7.0x EV/EBITDA on my calcs.
What do you think it should trade on? Maybe 10.0x plus for rapid growth?
Also, I would guess acquisition is part of the plan, so what can you buy a profitable ERP services business for? 4.0x to 5.0x I guess?
With $3.5m cash and trading on a high multiple, I would like to see them announce an acquisition to add to the organic growth so they can be re-rated to a high growth multiple of over 10.0x EV/EBITDA.
With the right deal adding $6m revenue and say $1.0m EBITDA (giving annualised $20m revenue and $3.2m adjusted for R&D), you could justify a valuation of 10.0 cents FY18
Interested in your thoughts.
- Forums
- ASX - By Stock
- JCS
- JCurve Solutions (JCS) - Oracle
JCS
jcurve solutions ltd
Add to My Watchlist
11.4%
!
3.1¢

JCurve Solutions (JCS) - Oracle, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.1¢ |
Change
-0.004(11.4%) |
Mkt cap ! $10.24M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 3.1¢ | $536 | 17.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 81379 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 377308 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 81379 | 0.031 |
1 | 77000 | 0.026 |
1 | 400000 | 0.025 |
1 | 70000 | 0.014 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 377308 | 2 |
0.036 | 1105808 | 1 |
0.050 | 162000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 10.42am 15/07/2025 (20 minute delay) ? |
Featured News
JCS (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online